This inventor holds 1 USPTO granted patent. Top assignee: Chengdu New Radiomedicine Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xianjin Luo: Innovator in Metal Nuclide-Loaded Carbon Microspheres
Introduction
Xianjin Luo is a prominent inventor based in Zhaotong, China. He has made significant contributions to the field of radiomedicine through his innovative work on metal nuclide-loaded carbon microspheres. His research focuses on enhancing the safety and efficacy of radioactive materials used in clinical applications.
Latest Patents
Xianjin Luo holds a patent for a "Metal nuclide-loaded carbon microsphere (CMS), preparation method, and use thereof." This invention provides a method for preparing a metal nuclide-loaded CMS that can stably exist in an aqueous solution at temperatures lower than 180° C and pressures below 10 MPa. The dissolution rate of the metal nuclide in the aqueous solution is remarkably low, at less than 0.1%. Even after undergoing moist-heat sterilization at 121° C for 15 minutes, the radionuclide release rate remains below 0.1%. This innovation significantly reduces the safety risks associated with radioactive microsphere products in clinical use.
Career Highlights
Xianjin Luo is associated with Chengdu New Radiomedicine Technology Co., Ltd., where he continues to advance research in radiomedicine. His work has garnered attention for its potential to improve patient safety and treatment outcomes in medical applications involving radioactive materials.
Collaborations
Xianjin Luo collaborates with notable colleagues, including Jun Zhang and Maoliang Li. Their combined expertise contributes to the innovative research and development efforts at their company.
Conclusion
Xianjin Luo's contributions to the field of radiomedicine through his patented innovations highlight his role as a key inventor in advancing safety in clinical applications. His work exemplifies the importance of innovation in improving medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile